- Home
- IPAR vs XENE Comparison
IPAR vs XENE Comparison
Compare IPAR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPAR | XENE |
|---|---|---|
| Founded | 1982 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.2B |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IPAR | XENE |
|---|---|---|
| Price | $91.46 | $55.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 12 |
| Target Price | ★ $125.50 | $67.25 |
| AVG Volume (30 Days) | 226.2K | ★ 1.4M |
| Earning Date | 05-11-2026 | 05-28-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | ★ 2.34 | N/A |
| EPS | ★ 5.24 | N/A |
| Revenue | ★ $1,317,700,000.00 | $311,000.00 |
| Revenue This Year | $4.47 | N/A |
| Revenue Next Year | $8.23 | $2,823.63 |
| P/E Ratio | $17.32 | ★ N/A |
| Revenue Growth | ★ 21.26 | N/A |
| 52 Week Low | $77.21 | $26.74 |
| 52 Week High | $142.50 | $62.91 |
Technical Indicators
Market Signals| Indicator | IPAR | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 37.49 | 64.27 |
| Support Level | $81.93 | $38.36 |
| Resistance Level | $102.38 | N/A |
| Average True Range (ATR) | 3.58 | 2.44 |
| MACD | -1.20 | 1.52 |
| Stochastic Oscillator | 14.97 | 64.63 |
Price Performance
Historical ComparisonAbout IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.